Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Expression of extracellular matrix proteins: tenascin-C, fi bronectin and galectin-3 in prostatic adenocarcinoma (CROSBI ID 225099)

Prilog u časopisu | izvorni znanstveni rad

Ulamec, Monika ; Tomas, Davor ; Džombeta, Tihana ; Tomašković, Igor ; Spajić, Borislav ; Krušlin, Božo Expression of extracellular matrix proteins: tenascin-C, fi bronectin and galectin-3 in prostatic adenocarcinoma // Journal of health science (Rosemead), 5 (2016), 3; 1-6. doi: 10.17532/jhsci. 2015.314

Podaci o odgovornosti

Ulamec, Monika ; Tomas, Davor ; Džombeta, Tihana ; Tomašković, Igor ; Spajić, Borislav ; Krušlin, Božo

engleski

Expression of extracellular matrix proteins: tenascin-C, fi bronectin and galectin-3 in prostatic adenocarcinoma

ABSTRACT Introduction: The interchanged stromal-epithelial relations and altered expression profi les of various extracellular matrix (ECM) proteins creates a suitable microenvironment for cancer development and growth. We support the opinion that remodeling of the extracellular matrix plays an important role in the cancer progression. The aim of this study was to examine the expression of ECM proteins tenascin-C, fi bronectin and galectin-3 in prostatic adenocarcinoma. Methods: Glands and surrounding stroma were analyzed in randomly selected specimens from 52 patients with prostate cancer and 28 patients with benign prostatic hyperplasia (BHP). To evaluate the intensity of tenascin-C, fi bronectin and galectin-3 expression the percentage of positively immunostained stromal cells was examined. Results: Compared to BPH, stroma of prostatic adenocarcinoma showed statistically signifi cant increase in tenascin-C expression (p < 0.001), predominantly around neoplastic glands, while fi bronectin (p = 0.001) and galectin-3 (p < 0.001) expression in the same area was decreased. Conclusions: Our study confi rms changes in the expression of ECM proteins of prostate cancer which may have important role in the cancer development.

ECM remodeling; fi bronectin; galectin-3; tenascin-C; prostatic adenocarcinoma

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

5 (3)

2016.

1-6

objavljeno

2166-5966

2166-5990

10.17532/jhsci. 2015.314

Povezanost rada

Temeljne medicinske znanosti, Kliničke medicinske znanosti

Poveznice